Xconomy | Kendall Square - 
					Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date  ▴ Xconomist Location
Biogen Idec, Elan Start First Cancer Trial With Tysabri Luke Timmerman 09/05/08 Boston
Pharmas Flock to Sermo, Biogen Idec Takes Another Tack with MS, $400M More for the Broad Institute, & More Life Sciences News Rebecca Zacks 09/04/08 Boston
ZymoGenetics Hands Over Atacicept Rights to Partner, Merck KGaA Luke Timmerman 09/03/08 Seattle
Corporate Life Sciences VCs on the Rise in New England—the List Ryan McBride 09/03/08 Boston
Proteostasis Therapeutics Procures $45M, Stealthy Startup Gets Serious About Shampoo, MA Life Sciences Center Chief Shares Her Plans, & More Life Sciences News Rebecca Zacks 08/27/08 Boston
Trubion Pushing Forward Arthritis Trials, Working to Re-Ignite the Spark for Investors Luke Timmerman 08/26/08 Seattle
Announcing Xconomy’s Next Forum: How to Build A Life Sciences Company Robert Buderi 08/25/08 Boston
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge Luke Timmerman 08/14/08 Boston
Follica’s Fortunes Growing, Icahn’s Biogen Holdings Mounting, Genzyme’s Mipomersen Work Progressing, & More Life Sciences News Rebecca Zacks 08/13/08 Boston
Stromedix Drug Gets Orphan Status Rebecca Zacks 08/12/08 Boston
Icahn Ups Biogen Idec Stake to 6 Percent—Bought Big on Tysabri Woes Ryan McBride 08/12/08 Boston
Vertex Cystic Fibrosis Program on the Rise, Biogen and Partner Fall on Tysabri News, Alnylam Stakes RNAa IP Claim, & More Life Sciences News Rebecca Zacks 08/06/08 Boston
Biogen Idec, Elan Shares Plummet on News of Two PML Cases With Tysabri Luke Timmerman 08/01/08 Boston
Biogen Idec, Elan Report Two New Cases of Rare Brain Infection in Tysabri Patients Luke Timmerman 07/31/08 Boston
Helicos Looking to Grow in Bay State, Thanks to Gov. Patrick’s Life Sciences Initiative Luke Timmerman 07/31/08 Boston
Icahn’s Nominee to Yahoo’s Board Winds up on Biogen Idec’s, Epix CEO Steps Down, Caliper Comes to Drugs’ Rescue, & More Life Sciences News Rebecca Zacks 07/30/08 Boston
Genzyme Pursues Multiple Sclerosis Market, Biogen Reports Progress in Same, BG Medicine Swallows $40 Million Cash Bolus, & More Life Sciences News Rebecca Zacks 07/23/08 Boston
Biogen Idec, Elan Say More Than 31,800 Patients Taking Tysabri For MS Luke Timmerman 07/22/08 Boston
Biogen Idec Isn’t Sweating Possible Sale of Genentech to Roche Luke Timmerman 07/22/08 Boston
Genzyme Reaching For a Slice From Biogen’s Breadbasket, Multiple Sclerosis Drugs Luke Timmerman 07/17/08 Boston
Health 2.0 Firms in the Spotlight, Biogen Board in the Clear, Alnylam in Asia, & More Life Sciences News Rebecca Zacks 06/25/08 Boston
Seeding Labs Kickstarts Science in Developing Countries Erik Mellgren 06/24/08 Boston
Icahn Nominee Concedes Defeat at Biogen Idec Annual Meeting Robert Buderi 06/19/08 Boston
Genzyme Seeks Dual Approval, Google Health Picks Another Massachusetts Partner, Biogen Shareholders To Provide Closure (Maybe), & More Life Science News Rebecca Zacks 06/19/08 Boston
Icahn Nominee to Biogen Idec Board Pledges to Work With Current Management to Restore Research Operations to Past Greatness Robert Buderi 06/18/08 Boston
Washington Biotechies Showing Off the Green (Trees) at BIO Conference Luke Timmerman 06/17/08 Seattle
Biogen Directors Win Backing From Third Advisory Firm, Icahn Could Be Heading For Defeat Luke Timmerman 06/12/08 Boston
Vertex Moves Hepatitis Drug Forward, Merrimack Rakes in $60M, Biogen and Icahn Trade Barbs, & More Life Sciences News Rebecca Zacks 06/12/08 Boston
Biogen Idec’s Nominees Win Support from Shareholder Advisory Firms Luke Timmerman 06/10/08 Boston
Icahn Jabs Biogen Idec, Says Its Board Had `Very Little’ Input in Sale Process Luke Timmerman 06/05/08 Boston
Page 1 of 3 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.